Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

People with alopecia areata may be more likely to have a certain type of hearing loss.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

c-kit affects hair growth and color in alopecia areata and androgenetic alopecia.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Diphenylcyclopropenone treatment helps prevent hair loss relapse in alopecia areata patients.

A woman's total hair loss was linked to a Borrelia infection and was reversed with appropriate treatment.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

A horse with severe hair loss was diagnosed with alopecia areata and a yeast infection.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

The guidelines offer updated treatment recommendations for alopecia areata in Korea using topical and device-based methods.

The review shows how to properly diagnose and treat the loss of eyebrow and eyelash hair.